TWST (STOCKS)
Twist Bioscience Corporation Common Stock
$82.605000
+1.815000 (+2.25%)
Prev close: $80.790000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Emily Marine Leproust
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,143.92M
- Employees
- 923
- P/E (TTM)
- -60.80
- P/B (TTM)
- 11.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $409.48M |
| Benefits Costs and Expenses | $490.01M |
| Cost Of Revenue | $196.25M |
| Costs And Expenses | $548.30M |
| Gross Profit | $213.23M |
| Operating Expenses | $352.05M |
| Selling, General, and Administrative Expenses | $272.95M |
| Research and Development | $71.89M |
| Operating Income/Loss | -$138.82M |
| Income/Loss From Continuing Operations After Tax | -$81.28M |
| Income/Loss From Continuing Operations Before Tax | -$80.53M |
| Income Tax Expense/Benefit | $744.00K |
| Net Income/Loss | -$81.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$81.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$81.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.32 |
| Diluted Earnings Per Share | -$1.33 |
| Basic Average Shares | 121,590,000 |
| Diluted Average Shares | 122,759,000 |
| Assets | $676.21M |
| Current Assets | $323.44M |
| Inventory | $33.52M |
| Prepaid Expenses | $9.34M |
| Other Current Assets | $280.59M |
| Noncurrent Assets | $352.78M |
| Fixed Assets | $111.23M |
| Other Non-current Assets | $241.55M |
| Liabilities | $221.12M |
| Current Liabilities | $119.98M |
| Accounts Payable | $14.68M |
| Wages | $27.00M |
| Other Current Liabilities | $78.29M |
| Noncurrent Liabilities | $101.14M |
| Equity | $455.09M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $455.09M |
| Liabilities And Equity | $676.21M |
| Net Cash Flow From Operating Activities | -$55.59M |
| Net Cash Flow From Operating Activities, Continuing | -$55.59M |
| Net Cash Flow From Investing Activities | -$44.44M |
| Net Cash Flow From Investing Activities, Continuing | -$44.44M |
| Net Cash Flow From Financing Activities | $11.84M |
| Net Cash Flow From Financing Activities, Continuing | $11.84M |
| Exchange Gains/Losses | $95.00K |
| Net Cash Flow | -$88.10M |
| Net Cash Flow, Continuing | -$88.19M |
| Comprehensive Income/Loss | -$81.25M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$81.25M |
| Other Comprehensive Income/Loss | $23.00K |